Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance

Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance


Hong Kong is reducing the amount of time travelers will need to serve hotel quarantine, from seven days down to three starting Friday.

“The seven-day quarantine hotel arrangement will be changed to three days in a quarantine hotel, plus four days of home medical surveillance,” Chief Executive John Lee said at a press conference Monday.

After completing the hotel quarantine, travelers can stay at home or in a hotel for the four days of surveillance. During this period people will be able to leave their place of residence, but cannot enter “places where there is active checking of vaccine passes,” Lee said in Cantonese.

That includes bars, pubs, gyms and beauty parlors. People are also not allowed to visit nursing homes, schools and specified medical premises during the surveillance period.

“They cannot participate in any activities where masks are to be taken off,” Lee added. If they test negative on a rapid antigen test, they can take public transportation, go to work and enter shopping malls, he said.

“We have to strike a balance between risk level as well as our economic activity. Where risks could be controlled, we want to preserve maximum movement of people and to maintain Hong Kong’s competitiveness,” Lee said.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Health

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that resulted in short supplies of Novo Nordisk ‘s Wegovy and Eli Lilly ‘s Zepbound. There were insurance coverage issues for these pricey treatments, […]

Read More
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More